A combined technological scheme for purification of undiluted high-strength wastewater produced in the shale oil industry was proposed. The initial values of chemical oxygen demand (COD), biological oxygen demand (BOD 7) and phenols in the studied pyrogenic wastewater samples were up to 45, 35 and 1 g/L, respectively. Furthermore, the wastewater had a high toxicity to indicator organism Daphnia Magna (EC 50 = 0.34%) and caused inhibition of oxygen uptake rate (IC 50 = 3.4%) and nitrification rate (IC 50 = 0.7%) in activated sludge treatment. The combination of air stripping, coagulation-flocculation, batch distillation, activated sludge and the Fenton oxidation processes reduced all measured parameters more than 95%. Consequently, a treatment scheme applicable to pyrogenic wastewater was developed.
In this research, various combinations of physicochemical (coagulation, Fenton process and ozonation) and biological (aerobic oxidation) treatment methods were used to purify wastewater originating from wood soaking basins in plywood production industry. Although the wastewater has good biodegradability (92 %), there is a high fraction of organic material expressed as recalcitrant chemical oxygen demand (COD) of approximately 360 mg L -1 . High fraction of organics is caused by woodoriginating water-soluble material, i.e. extractives, including lignin and tannins. It was found that optimal treatment method for hardwood soaking basin wastewater is the combination of biological pre-treatment, chemical treatment with Fenton reagent and biological post-treatment. Under optimal conditions of combined process performance, up to 99 % removal of the organic loads, nitrogen and phenols was achieved. Besides achieving target discharge limits stated for industrial wastewater, the effluent met the requirements set for municipal wastewater treatment plants, making the treated water acceptable for subsequent discharge into natural water bodies: treated water COD = 90 ± 3 mg L -1 ; BOD 7 = 10 ± 1 mg L -1 . The main result of the present work was the establishment of sustainable, efficient and economically feasible process to treat the wastewater with minimised chemicals consumption. This differs considerably from approaches such as coagulation or wet oxidation, used to treat similar water types according to the literature, and is readily applicable for the production facilities of various scales, including small and medium enterprises, without the need to make changes in existing technological schemes.
Industrial wastewater frequently contains substances which inhibit activated sludge treatment processes. Inhibitory characteristics of different substances are usually evaluated based on testing the impact of respective substance on activated sludge nitrification or oxygen uptake rates. However, denitrification is always before aerobic processes in conventional activated sludge treatment plants and thereby more exposed to inhibitory compounds. There is no easily applicable and validated method available for determination of denitrification process efficiency and inhibition. In this study, a method for evaluation of inhibition on the activated sludge denitrification process was developed and validated using 3,5-dichlorophenol (3,5-DCP) as a model inhibitory compound and additionally controlled with real wastewater produced in the shale oil industry. Average IC50 value (5.5 ± 2.2 mg L−1) for 3,5-DCP showed that denitrifiers were less sensitive than nitrifiers (IC50 = 2.9 ± 0.7 mg L−1) and more sensitive than aerobic heterotrophs (IC50 = 7.2 ± 2.4 mg L−1). Methodological aspects like accumulation of nitrite nitrogen, acclimatization of biomass and technical issues were discussed. Achieved validation characteristics were similar with ISO Standards estimating activated sludge nitrification and oxygen uptake rates, which proves the reliability of the method: standard deviation, 95.4% confidence level, relative standard deviation were calculated to be 2.2 mg L−1, 1.2 … 9.8 mg L−1 and 39.2%, respectively.
Wastewater in industrial regions frequently contains substances which are potentially inhibitory to activated sludge treatment processes. Enhanced biological phosphorus removal (EBPR) is vulnerable to process inhibition mostly because of the location at the beginning of the treatment process and complex characteristics of influent. Much knowledge has been developed on the EBPR process; nonetheless, methods used for estimation of the process inhibition vary largely. There is no easily applicable and reliable method available for rapid determination of inhibition of the EBPR process. In this study, a method for evaluation of inhibition on the EBPR process was developed and controlled. In contrast with previous research, a fresh non-acclimated inoculum was used to enhance the possibility to predict the impact for wastewater treatment plant. The efficiency of the process was evaluated based on the values of orthophosphate release and uptake, synthesis and consumption of polyhydroxyalkanoates. 3,5-dichlorophenol (3,5-DCP) was used as a model inhibitory compound. It was found that the EBPR inhibition tests using a non-acclimated sludge need wastewater as the organic carbon source. Furthermore, the length of aerobic period substantially influenced the inhibition test resultsachieved maximum inhibitory concentration (IC 50) values were 2.4 times higher when aerobic phase was 6 h instead of 1.5 h. Consequently, extended aeration period was suggested to diminish the inhibition effect. Finally, the impact of the 3,5-DCP on different activated sludge treatment process using respective standard methods was tested and compared. It was found that EBPR process was similarly to the nitrification a sensitive activated sludge process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.